Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC Settles Big With Sensa, Other Weight-Loss Marketers

This article was originally published in The Tan Sheet

Executive Summary

FTC settles with Sensa products and three other weight-loss product marketers, and launches its “gut check” voluntary media partnership program to prevent bogus claims. A firm cited in FTC’s 2011 investigation of human chorionic gonadotropin product ads also reached a settlement with the agency.

You may also be interested in...



FTC Pulls Curtain On Latest Initiative Against Bogus Weight Loss Claims

Agency based new website to help consumers identify false weight loss claims not on recent enforcement, but on previous investigations, including a 2011 complaint. "Those claims are lies," says official announcing website's launch.

Sensa Class Action Complaint Gets Second Shot At Certification

A federal judge denied certification without prejudice, allowing plaintiff's attorneys to file an amended complaint with arguments and evidence countering reasons for denying certification as a class. Two other complaints were resolved in settlements following FTC's settlement with Sensa Products and its parent firm in 2014 for $26.5m.

Ad Firm Behind Bogus Weight Loss Claims Fined $2M: Health And Wellness Industry News

FTC and Maine would collect $2m under a settlement on complaint that Marketing Architects created ads for a weight loss supplement firm already targeted by FTC for false claims; Long Life Unlimited warned on claims; and UK catalog claims healing powers for meristem.

Related Content

Topics

UsernamePublicRestriction

Register

OM003387

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel